Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
BIPHENYL COMPOUNDS AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2015/062486
Kind Code:
A1
Abstract:
The present invention relates to biphenyl compounds and uses thereof in medicine. Specifically, the present invention relates to a compound of Formula (I), or a stereoisomer, a geometric isomer, a tautomer, a mesomer, a racemate, an enantiomer, a diastereoisomer, an N-oxide, a hydrate, a solvate, a metabolite, a hydrolysate, a pharmaceutically acceptable salt or a prodrug thereof. The compound disclosed herein is used as a therapeutic agent particularly a GPR40 agonist for treating diabetes and metabolic disease in a patient.

Inventors:
ZHANG YINGJUN (CN)
WANG XIAOJUN (CN)
YANG XINYE (CN)
PAN SHENGQIANG (CN)
WU CHENLIANG (CN)
MA FACHENG (CN)
WU SHOUTAO (CN)
WU JUNWEN (CN)
Application Number:
PCT/CN2014/089725
Publication Date:
May 07, 2015
Filing Date:
October 28, 2014
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SUNSHINE LAKE PHARMA CO LTD (CN)
International Classes:
C07D405/12; A61K31/397; A61P3/10; C07D307/80; C07D407/12; C07D409/12; C07D413/12
Domestic Patent References:
WO2008001931A22008-01-03
WO2005087710A12005-09-22
WO2004106276A12004-12-09
Foreign References:
CN103145663A2013-06-12
Other References:
NOBUYUKI NEGORO ET AL.: "Optimization of (2, 3-Dihydro-1-benzofuran-3-yl)acetic Acids: Discovery of a Non-Free Fatty Acid-Like, Highly Bioavailable G Protein-Coupled Receptor 40/Free Fatty Acid Receptor 1 Agonist as a Glucose-Dependent Insulinotropic Agent", J. MED. CHEM., vol. 55, no. 8, 10 April 2012 (2012-04-10), pages 3965, XP002744049, DOI: doi:10.1021/jm300170m
Attorney, Agent or Firm:
TSINGYIHUA INTELLECTUAL PROPERTY LLC (Trade Building Zhaolanyuan, Tsinghua University,Qinghuayuan, Haidian District, Beijing 4, CN)
Download PDF: